Dengue vaccines : dawning at last?
The need for a dengue vaccine is more pressing than ever. Dengue—a mosquito-borne viral infection caused by any of the four dengue virus serotypes—is regarded as the most important arboviral disease globally, because more than 50% of the world's population live in regions at risk of the disease...
Saved in:
Main Author: | Wilder-Smith, Annelies |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/103775 http://hdl.handle.net/10220/24583 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Dengue : challenges for policy makers and vaccine developers
by: Wilder-Smith, Annelies, et al.
Published: (2014) -
Moving forward with Takeda's live chimeric tetravalent dengue vaccine
by: Wilder-Smith, Annelies
Published: (2017) -
Edging closer towards the goal of a dengue vaccine
by: Wilder-Smith, Annelies, et al.
Published: (2016) -
Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine
by: Wilder-Smith, Annelies, et al.
Published: (2016) -
Haze and dengue : the unanswered questions
by: Earnest, Arul, et al.
Published: (2014)